Definium Therapeutics, formerly Mind Medicine (MNMD), unveiled its new brand. In conjunction with the rebrand, the company’s Nasdaq ticker symbol will change to (DFTX) effective at market open on January 13.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNMD:
- Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
- Needham names Mind Medicine top pick, adds to Conviction List
- Ametek, MindMed, Atai, Prime and KB Home Trending
- MindMed Expands Into Autism: What Investors Should Know About the New MM402 Trial
- Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal